Helicobacter pylori and duodenal ulcer. Long-term results of triple sucralfate antibiotic therapy
Dorval, E.D.; Loulergue, J.; Barbieux, J.P.; Metman, E.H.; de Muret, A.
Gastroenterologie Clinique et Biologique 15(11): 863-864
1991
ISSN/ISBN: 0399-8320 PMID: 1769484 Document Number: 370653
Document emailed within 1 workday
Related Documents
Sanfélix Genovés, J.; Pereiró Berenguer, I.; Jimeno Bernard, R.; García Tell, G.; Navarro Pérez, J.; Bonet Pla, A.; Ballester Belenguer, J. 1998: Helicobacter pylori: 6-day triple therapy in duodenal ulcer Atencion Primaria 21(8): 517-521Labenz, J.; Gyenes, E.; Rühl, G.H.; Börsch, G. 1993: Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease Medizinische Klinik 88(5): 297-299
Peetsalu, M.; Valle, J.; Härkönen, M.; Maaroos, H-Ingrid.; Peetsalu, A. 2005: Changes in the histology and function of gastric mucosa and in Helicobacter pylori colonization during a long-term follow-up period after vagotomy in duodenal ulcer patients Hepato-Gastroenterology 52(63): 785-791
Kepekci, Y.; Kadayifci, A. 1999: Does the eradication of Helicobacter pylori cure duodenal ulcer disease in communities with a high prevalence rate? Comparison with long-term acid suppression International Journal of Clinical Practice 53(7): 505-508
Larsen, B.; Iversen, T.O.; Linde, N.C.; Rahbek, I.; Pedersen, N.T. 1992: Effect of 1-year long-term treatment with sucralfate on symptomatic recurrence of duodenal ulcer Ugeskrift for Laeger 154(45): 3147-3149
Kullavanijaya, P.; Gonlachanvit, S.; Mahachai, V.; Kladchareon, N. 2000: Eradication of Helicobacter pylori with lansoprazole based triple therapy in peptic ulcer disease Journal of the Medical Association of Thailand 83(3): 230-235
Gaidar, I.A.; Stepanova, E.V.; Mosiichuk, L.N.; Demeshkina, L.V.; Sheikhetova, G.A.; Bespalova, E.V.; Kudriavtseva, V.E.; Vcherashniaia, N.N. 2001: Particular features of the relationship of Helicobacter pylori and G cells in patients with duodenal ulcer, with special reference to the Helicobacter pylori strain Likars'ka Sprava 2001(4): 176-177
Figueroa, G.; Acuña, R.; Troncoso, M.; Portell, D.P.; Toledo, M.S.; Albornoz, V.; Vigneaux, J. 1996: Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients American Journal of Gastroenterology 91(7): 1395-1399
Karita, M.; Morshed, M.G.; Ouchi, K.; Okita, K. 1994: Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate American Journal of Gastroenterology 89(7): 1032-1035
Flores, S.; Opazo, H.; Valderrama, D.; Aguilera, R.; Marchese, A.; Valderrama, S. 2000: Triple therapy of short-term with azithromycin, amoxycillin and omeprazole for the eradication of Helicobacter pylori Revista Medica de Chile 128(5): 509-512
Gisbert, J.P.; Boixeda, D.; de Rafael, L.; Martín de Argila, C.; Bermejo, F.; García Plaza, A. 1995: The effect of "triple therapy" on the eradicating of H. pylori and the healing of a duodenal ulcer. the initial study and 6 months later Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 87(3): 193-198
Vasil'ev, I.V.; Nikol'skaia, K.A. 2005: Results of the treatment of duodenal ulcer associated with Helicobacter pylori and combined with gastroesophageal reflux disease Eksperimental'naia i Klinicheskaia Gastroenterologiia 6: 61-64
Ben Ammar, A.; Cheikh, I.; Ouerghi, H.; Chaabouni, H.; Kchaou, M.; Ben Mami, N. 2002: Prevalence of Helicobacter pylori infection in duodenal ulcer. Data of a prospective study apropos of 78 NSAID-negative patients with duodenal ulcer La Tunisie Medicale 80(10): 599-604
Aminian, K.; Farsad, F.; Ghanbari, A.; Fakhreih, S.; Hasheminasab, S.M. 2010: A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 31(4): 303-307
Adamek, R.J.; Opferkuch, W.; Wegener, M. 1995: Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection American Journal of Gastroenterology 90(1): 168-169
Iser, J.H.; Buttigieg, R.J.; Iseli, A. 1994: Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer Medical Journal of Australia 160(4): 192-196
Amendola, M.; Farias, R.; Katz, J.; Luna, P.; Ianella, M.; Musi, A.; Boerr, L.; Valero, J.; Kogan, Z.; Corti, R. 1999: Absence of bleeding recurrence of peptic ulcer after long term follow-up of successful eradication of Helicobacter pylori Acta Gastroenterologica Latinoamericana 29(2): 47-50
Henry, A.; Batey, R.G. 1998: Low prevalence of Helicobacter pylori in an Australian duodenal ulcer population: NSAIDitis or the effect of ten years of H. pylori treatment? Australian and New Zealand Journal of Medicine 28(3): 345
Nagashima, R.; Hinohara, Y.; Hirano, T. 1980: Selective binding of sucralfate to ulcer lesion. III. Experiments in rats with duodenal ulcer receiving 14C-sucralfate Arzneimittel-Forschung 30(1): 88-91
Barbara, L.; Biasco, G.; Capurso, L.; Dobrilla, G.; Lalli, A.; Paganelli, G.M.; Pallone, F.; Torsoli, A. 1990: Effects of sucralfate and sulglycotide treatment on active gastritis and Helicobacter pylori colonization of the gastric mucosa in non-ulcer dyspepsia patients American Journal of Gastroenterology 85(9): 1109-1113